NEW YORK, July 30, 2015 /PRNewswire/ -- The following
statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise
acquired securities of Avalanche Biotechnologies, Inc.
("Avalanche") (NASDAQ: AAVL) pursuant and/or traceable to the
Company's Initial Public Offering on or about July 31, 2014 and/or between July 31, 2014 and June 15,
2015.
You are hereby notified that a securities class action
lawsuit has been commenced in the USDC for the Northern District of
California. If you purchased or
otherwise acquired Avalanche securities pursuant and/or traceable
to the Company's Initial Public Offering on or about July 31, 2014 and/or between July 31, 2014 and June 15,
2015, your rights may be affected by this
action. To get more information go to:
http://zlk.9nl.com/avalanche-technologies-aavl or
contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972. There is no cost or obligation to
you.
The complaint alleges that throughout the Class Period
defendants issued materially false and misleading statements and/or
failed to disclose that Phase 2a of the study for its drug AVA-101
was not designed to show any statistical significance between the
active and control groups in the secondary
endpoints.
If you suffered a loss in Avalanche you have until
September 8, 2015 to request that
the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn't require that you serve as a lead
plaintiff.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-notifies-shareholders-of-avalanche-biotechnologies-inc-of-pendency-of-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-september-8-2015--aavl-300121440.html
SOURCE Levi & Korsinsky, LLP